Tamar Thompson Avidity Biosciences, Inc. (RNA) insider trading activity

RNA Quotes by TradingView

Tamar Thompson is Director of Avidity Biosciences, Inc.. Currently has a direct ownership of 6,692 shares of RNA, which is worth approximately $242,718. The most recent transaction as insider was on Jun 10, 2025, when has been sold 6,692 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.69K
Infinity% 3M change
n/a 12M change
Total Value Held $242,718

Tamar Thompson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2025
BUY
Grant, award, or other acquisition
-
6,692 Added 50.0%
6,692 Common Stock
Oct 07 2024
SELL
Open market or private sale
$1,349,400 $44.98 p/Share
30,000 Reduced 100.0%
0 Common Stock
Oct 07 2024
BUY
Exercise of conversion of derivative security
$828,900 $27.63 p/Share
30,000 Added 50.0%
30,000 Common Stock

Also insider at

CPRX
CATALYST PHARMACEUTICALS, INC. Healthcare
Director
TT

Tamar Thompson

Director
San Diego, CA

Track Institutional and Insider Activities on RNA

Follow Avidity Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNA shares.

Notify only if

Insider Trading

Get notified when an Avidity Biosciences, Inc. insider buys or sells RNA shares.

Notify only if

News

Receive news related to Avidity Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RNA